Fig. 4
From: Humoral immune response and safety of Sars-Cov-2 vaccine in people with multiple sclerosis
The association between three ranges of antibody levels (< 4.75 RU/ml, 4.75–10.25 RU/ml and > 10.25 RU/ml) and rate of side effects after COVID-19 vaccination (mostly Sinopharm) in 45 women with MS. “YES” and “No” are assigned to the presence and absence of side effects respectively